These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 9627130)
21. IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response. Bliss J; Van Cleave V; Murray K; Wiencis A; Ketchum M; Maylor R; Haire T; Resmini C; Abbas AK; Wolf SF J Immunol; 1996 Feb; 156(3):887-94. PubMed ID: 8558014 [TBL] [Abstract][Full Text] [Related]
22. 18β-glycyrrhetinic acid induces immunological adjuvant activity of Th1 against Candida albicans surface mannan extract. Kim J; Joo I; Kim H; Han Y Phytomedicine; 2013 Aug; 20(11):951-5. PubMed ID: 23746951 [TBL] [Abstract][Full Text] [Related]
23. Th1 adjuvant N-acetyl-D-glucosamine polymer up-regulates Th1 immunity but down-regulates Th2 immunity against a mycobacterial protein (MPB-59) in interleukin-10-knockout and wild-type mice. Shibata Y; Honda I; Justice JP; Van Scott MR; Nakamura RM; Myrvik QN Infect Immun; 2001 Oct; 69(10):6123-30. PubMed ID: 11553551 [TBL] [Abstract][Full Text] [Related]
24. Immunopotentiation of Different Adjuvants on Humoral and Cellular Immune Responses Induced by HA1-2 Subunit Vaccines of H7N9 Influenza in Mice. Song L; Xiong D; Hu M; Kang X; Pan Z; Jiao X PLoS One; 2016; 11(3):e0150678. PubMed ID: 26930068 [TBL] [Abstract][Full Text] [Related]
25. Immunological adjuvant effect of Boswellia serrata (BOS 2000) on specific antibody and cellular response to ovalbumin in mice. Gupta A; Khajuria A; Singh J; Singh S; Suri KA; Qazi GN Int Immunopharmacol; 2011 Aug; 11(8):968-75. PubMed ID: 21371582 [TBL] [Abstract][Full Text] [Related]
26. Fusion of a tumour-associated antigen to HIV-1 Tat improves protein-based immunotherapy of cancer. Giannouli C; Brulet JM; Gesché F; Rappaport J; Burny A; Leo O; Hallez S Anticancer Res; 2003; 23(4):3523-31. PubMed ID: 12926102 [TBL] [Abstract][Full Text] [Related]
27. The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers--a review and hypothesis. Becker Y Virus Genes; 2004 Jan; 28(1):5-18. PubMed ID: 14739648 [TBL] [Abstract][Full Text] [Related]
28. Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies. Bolhassani A; Zahedifard F; Taghikhani M; Rafati S Vaccine; 2008 Jun; 26(26):3362-70. PubMed ID: 18471945 [TBL] [Abstract][Full Text] [Related]
29. CpG-DNA stimulates cellular and humoral immunity and promotes Th1 differentiation in aged BALB/c mice. Maletto B; Rópolo A; Morón V; Pistoresi-Palencia MC J Leukoc Biol; 2002 Sep; 72(3):447-54. PubMed ID: 12223511 [TBL] [Abstract][Full Text] [Related]
30. The contribution of NT-gp96 as an adjuvant for increasing HPV16 E7-specific immunity in C57BL /6 mouse model. Mohit E; Bolhassani A; Zahedifard F; Taslimi Y; Rafati S Scand J Immunol; 2012 Jan; 75(1):27-37. PubMed ID: 21916914 [TBL] [Abstract][Full Text] [Related]
31. Leaf saponins of Quillaja brasiliensis enhance long-term specific immune responses and promote dose-sparing effect in BVDV experimental vaccines. Cibulski S; Rivera-Patron M; Suárez N; Pirez M; Rossi S; Yendo AC; de Costa F; Gosmann G; Fett-Neto A; Roehe PM; Silveira F Vaccine; 2018 Jan; 36(1):55-65. PubMed ID: 29174676 [TBL] [Abstract][Full Text] [Related]
32. Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus. Fotouhi F; Shaffifar M; Farahmand B; Shirian S; Saeidi M; Tabarraei A; Gorji A; Ghaemi A Arch Virol; 2017 May; 162(5):1251-1260. PubMed ID: 28120096 [TBL] [Abstract][Full Text] [Related]
33. CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice. Weeratna RD; Brazolot Millan CL; McCluskie MJ; Davis HL FEMS Immunol Med Microbiol; 2001 Dec; 32(1):65-71. PubMed ID: 11750224 [TBL] [Abstract][Full Text] [Related]
34. CpG DNA induces stronger immune responses with less toxicity than other adjuvants. Weeratna RD; McCluskie MJ; Xu Y; Davis HL Vaccine; 2000 Mar; 18(17):1755-62. PubMed ID: 10699323 [TBL] [Abstract][Full Text] [Related]
35. Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) is a potent enhancer of mixed Th1/Th2 immune responses in mice immunized with influenza virus antigens. Mutwiri G; Benjamin P; Soita H; Townsend H; Yost R; Roberts B; Andrianov AK; Babiuk LA Vaccine; 2007 Jan; 25(7):1204-13. PubMed ID: 17140708 [TBL] [Abstract][Full Text] [Related]
36. A new vaccine adjuvant (BOS 2000) a potent enhancer mixed Th1/Th2 immune responses in mice immunized with HBsAg. Khajuria A; Gupta A; Malik F; Singh S; Singh J; Gupta BD; Suri KA; Suden P; Srinivas VK; Ella K; Qazi GN Vaccine; 2007 Jun; 25(23):4586-94. PubMed ID: 17498851 [TBL] [Abstract][Full Text] [Related]
37. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses. Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093 [TBL] [Abstract][Full Text] [Related]
38. Immunization with a Recombinant Expression Vector Encoding NS3/NS4A of Hepatitis C Virus Genotype 3a Elicits Cell-Mediated Immune Responses in C57BL/6 Mice. Behzadi MA; Alborzi A; Kalani M; Pouladfar G; Dianatpour M; Ziyaeyan M Viral Immunol; 2016 Apr; 29(3):138-47. PubMed ID: 26909520 [TBL] [Abstract][Full Text] [Related]
39. Effect of rolipram, a phosphodiesterase IV inhibitor, on allergic footpad swelling using various adjuvants in mice. Yamaki K; Alam AH; Hossain MA; Taneda S; Yanagisawa R; Takano H; Yoshino S Scand J Immunol; 2005 Oct; 62(4):378-84. PubMed ID: 16253125 [TBL] [Abstract][Full Text] [Related]
40. Immuno-Stimulating Peptide Derived from HMGB1 is More Effective Than the N-Terminal Domain of Gp96 as an Endogenous Adjuvant for Improvement of Protein Vaccines. Talebi S; Bolhassani A; Azad TM; Arashkia A; Modaresi MH Protein Pept Lett; 2017; 24(3):190-196. PubMed ID: 28000571 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]